Tag Archives: mass spec

Rayno DX and Tools Mid Year Review and AACC Update: ABAX, ILMN, HOLX, TMO.. Update-1

Update 7/30 Hologic (HOLX) Beats by $0.03 beats on revenues: stock up 3.2% AH to $26.80. Hologic Announces Third Quarter Fiscal 2014 Operating Results | Seeking Alpha Update 7/29 Rally Is Cut Short By New Sanctions On Russian Industry-Sell-Off at 2:15 EDT Consumer Confidence at 90.9 vs Forecasts 85.0-Before Market Opens Diagnostics/Tools stocks trying to rally […]

Leave a comment Continue Reading →

Rodman&Renshaw Notes Part 2: Sequenom (SQNM)

Sequenom (SQNM) $7, Market Cap $529M, 76M Sh. Outstanding Sequenom presented a financial update and their plans for their T21 trisomy 21 noninvasive pre-natal test for fetal gene and chromosomal abnormalities. The Company plans to launch a CLIA LDT (lab developed test) by Q4 2011 and submit a PMA by late 2012. The T21 test […]

Comments Off Continue Reading →

Sequenom (SQNM) Catching Bids at $5.75

Sequenom is finding price support today at $5.75, volume of 4.6M at 1p, after a severe three  day downdraft triggered by their earnings release. Net loss for Q4 was $18.4M on Revenues of $10.8M. Cash position is $42M. Some pundits didn’t like the inability of the Company to give a detailed financial outlook but that […]

Comments Off Continue Reading →